This article has been retracted: A number of figure images in this paper were previously published in earlier papers. Figure 2E contains images from Figure 6C of another paper [1]. Figure 5D also contains images from two other published papers which have since been retracted [2, 3]. Figure 2C also contains images from Figure 2C of another published paper [4]. Images in Figure 3B and 5F are sourced from another published paper [5]. Figure 6B also contains images from another published paper [6]. Figure 5B has an image from Figure 4D in another published paper [7]. In addition, the authors are unable to reproduce the results represented in the paper. As a result, all authors have agreed to this retraction.
Original article: Oncotarget. 2017; 8:101649–101658. 101649-101658. https://doi.org/10.18632/oncotarget.21417
REFERENCES
- 1. Lin Y, Cheng K, Wang T, Xie Q, Chen M, Chen Q, Wen Q. miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer. Biomed Pharmacother. 2017; 95:1718–24. 10.1016/j.biopha.2017.09.074. [DOI] [PubMed] [Google Scholar]
- 2. Li R, Dong B, Wang Z, Jiang T, Chen G. MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1. Biomed Pharmacother. 2018; 102:988–95. 10.1016/j.biopha.2018.03.122. . Retraction in: Biomed Pharmacother. 2023; 114723. . [DOI] [PubMed] [Google Scholar]
- 3. Niu JT, Zhang LJ, Huang YW, Li C, Jiang N, Niu YJ. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7. Biochem Cell Biol. 2018; 96:752–60. 10.1139/bcb-2018-0047. . Retraction in: Biochem Cell Biol. 2023; 101:197. . [DOI] [PubMed] [Google Scholar]
- 4. Fei D, Sui G, Lu Y, Tan L, Dongxu Z, Zhang K. The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206. J Cell Mol Med. 2019; 23:1865–72. 10.1111/jcmm.14087. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 5. Yu B, Lv X, Su L, Li J, Yu Y, Gu Q, Yan M, Zhu Z, Liu B. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. PLoS One. 2016; 11:e0158961. 10.1371/journal.pone.0158961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Teng Y, Zhang Y, Qu K, Yang X, Fu J, Chen W, Li X. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3. Oncotarget. 2015; 6:40799–814. 10.18632/oncotarget.5695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Kim HS, Lee KS, Bae HJ, Eun JW, Shen Q, Park SJ, Shin WC, Yang HD, Park M, Park WS, Kang YK, Nam SW. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. Oncotarget. 2015; 6:8089–102. 10.18632/oncotarget.3512. [DOI] [PMC free article] [PubMed] [Google Scholar]